Merck (MRK) Beats Stock Market Upswing: What Investors Need to Know

18.06.24 23:50 Uhr

Werte in diesem Artikel
Aktien

117,80 EUR -0,20 EUR -0,17%

153,25 EUR -0,75 EUR -0,49%

Indizes

PKT PKT

PKT PKT

1.626,2 PKT 17,2 PKT 1,07%

18.748,2 PKT 213,6 PKT 1,15%

7.202,5 PKT 82,1 PKT 1,15%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

189,4 PKT 1,6 PKT 0,87%

40.000,9 PKT 247,2 PKT 0,62%

517,7 PKT 5,5 PKT 1,06%

9.929,9 PKT 107,0 PKT 1,09%

18.714,0 PKT 0,0 PKT 0,00%

18.722,6 PKT 205,8 PKT 1,11%

15.547,3 PKT 112,8 PKT 0,73%

7.343,5 PKT 77,6 PKT 1,07%

16.301,9 PKT 105,6 PKT 0,65%

2.725,8 PKT 12,2 PKT 0,45%

5.615,4 PKT 30,8 PKT 0,55%

18.717,7 PKT 209,7 PKT 1,13%

In the latest trading session, Merck (MRK) closed at $127.99, marking a +0.38% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.25%. Elsewhere, the Dow gained 0.15%, while the tech-heavy Nasdaq added 0.03%.Coming into today, shares of the pharmaceutical company had lost 2.66% in the past month. In that same time, the Medical sector gained 0.11%, while the S&P 500 gained 3.34%.The investment community will be closely monitoring the performance of Merck in its forthcoming earnings report. The company is scheduled to release its earnings on July 30, 2024. The company is expected to report EPS of $2.14, up 203.88% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $15.88 billion, up 5.65% from the prior-year quarter.For the full year, the Zacks Consensus Estimates project earnings of $8.62 per share and a revenue of $64.4 billion, demonstrating changes of +470.86% and +7.13%, respectively, from the preceding year.Any recent changes to analyst estimates for Merck should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.59% lower. Merck is holding a Zacks Rank of #3 (Hold) right now.In terms of valuation, Merck is presently being traded at a Forward P/E ratio of 14.79. This valuation marks a premium compared to its industry's average Forward P/E of 14.43.It is also worth noting that MRK currently has a PEG ratio of 2.46. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Large Cap Pharmaceuticals industry was having an average PEG ratio of 1.78.The Large Cap Pharmaceuticals industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 156, placing it within the bottom 39% of over 250 industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.Where Will Stocks Go…If Biden Wins? If Trump Wins?The answers may surprise you.Since 1950, even after negative midterm years, the market has never had a lower presidential election year. With voters energized and engaged, the market has been almost unrelentingly bullish no matter which party wins!Now is the time to download Zacks' free Special Report with 5 stocks that offer extreme upside for both Democrats and Republicans…1. Medical manufacturer has gained +11,000% in the last 15 years.2. Rental company is absolutely crushing its sector.3. Energy powerhouse plans to grow its already large dividend by 25%.4. Aerospace and defense standout just landed a potentially $80 billion contract.5. Giant Chipmaker is building huge plants in the U.S. Hurry, Download Special Report FREE >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Merck

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Merck

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Merck KGaA

Analysen zu Merck KGaA

DatumRatingAnalyst
10.07.2024Merck BuyUBS AG
25.06.2024Merck Market-PerformBernstein Research
25.06.2024Merck BuyUBS AG
25.06.2024Merck OverweightJP Morgan Chase & Co.
25.06.2024Merck OverweightBarclays Capital
DatumRatingAnalyst
10.07.2024Merck BuyUBS AG
25.06.2024Merck BuyUBS AG
25.06.2024Merck OverweightJP Morgan Chase & Co.
25.06.2024Merck OverweightBarclays Capital
25.06.2024Merck BuyJefferies & Company Inc.
DatumRatingAnalyst
25.06.2024Merck Market-PerformBernstein Research
06.12.2023Merck HaltenDZ BANK
27.11.2023Merck HaltenDZ BANK
27.04.2023Merck HaltenDZ BANK
10.11.2022Merck NeutralUBS AG
DatumRatingAnalyst
06.03.2023Merck VerkaufenDZ BANK
02.03.2023Merck SellGoldman Sachs Group Inc.
07.02.2023Merck SellGoldman Sachs Group Inc.
02.02.2023Merck VerkaufenDZ BANK
15.11.2022Merck SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Merck KGaA nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"